Program & Downloads
Click here to download the entire book (139KB) – To navigate in the pages, please use the search tool or the bookmarks.
Click here to view the speakers list
CONGRESS 2009
- 8:45 Introduction : Viral Hepatitis in 2009 - Patrick MARCELLIN (France)
-
9:00 – 10:30
Chairs :
Teresa WRIGHT (USA) Nezam AFDHAL (USA)
-
9:00
How to use the virological tools for the optimal follow up of chronic hepatitis C
- Jean-Michel PAWLOTSKY (France)
Download
- 9:20 What are the co-morbidities influencing the management of patients and the response to therapy ? - Alfredo ALBERTI (Italy)
-
9:40
Non invasive fibrosis markers and/or liver biopsy ?
- Pierre BEDOSSA (France)
Download
- 10:00 Round table - All speakers
- 10:30 - 11:00 Coffee break
-
11:00 – 12:30
Optimizing therapy in real life illustrated with clinical cases
Chairs :
Peter FERENCI (Austria) Graham FOSTER (UK)
-
11:00
Optimizing therapy in real life illustrated with clinical cases Optimal therapy in genotype 1 patients
- Stefan ZEUZEM (Germany)
Download
-
11:20
Optimal therapy in genotype 2 and 3 patients
- Antonio CRAXI (Italy)
Download
-
11:40
Optimal therapy in genotype 4 patients
- Sanaa KAMAL (Egypt)
Download
- 12:00 Round table - All speakers
-
12:30 – 14:00 Luncheons Room 1
The burden of hepatitis C in Europe. Epidemiology, actions to increase awareness and access to care
Chair: Daniel LAVANCHY (Switzerland)
Room 3
Clinical Management of hepatitis C in an environment with limited access to treatment
Chair: Eugene SCHIFF (USA)
Speaker:
Andrzej HORBAN (Poland)
Download
Room 5
Management of HIV-HCV co-infected patients
Chair: Stanislas POL (France)
Speaker:
Juergen ROCKSTROH (Germany)
Download
Room 6
French Luncheon : comment prendre en charge les patients atteints d’hépatite C avec les médicaments disponibles dans mon pays.
Chair: Daniel DHUMEAUX (France)
Speakers:
Christoph SARRAZIN (Germany)
Download
Abdellah ESSAID EL FEYDI (Maroc)
Download
Saadi BERKANE (Algeria)
Download
-
14:00 – 16:00
Chairs :
Masao OMATA (Japan) Marc BOURLIERE (France)
- 14:00 Retreatment : who and how ? - Jenny HEATHCOTE (Canada)
-
14:15
New drugs : Enzyme inhibitors
- Tarik ASSELAH (France)
Download
-
14:45
What future for ribavirin ?
- Mitchell SHIFFMAN (USA)
Download
- 15:00 Round table - All speakers
- 15:30 Clinical case - Eugene SCHIFF (USA)
- 16:00 - 16:30 Coffee break
- 16:30 – 18:00 State of the Art Lecture - Patrick MARCELLIN (France)
-
16:30
The global burden of hepatitis C
- Daniel LAVANCHY (Switzerland)
Download
- 16:50 1989 -2009 : HCV twenty years after From B to non B to C : the historical evolution of hepatitises viruses - Harvey ALTER (USA)
-
17:10
The HCV discovery
- Michael HOUGHTON (USA)
Download
- 17:30 The history of the "natural history" of hepatitis C - Leonard SEEFF (USA)
- 18:00 Awards ceremonyw
- 20:00 Congress Dinner
-
8:30 - 10:00
Chairs :
Michael MANNS (Germany) Feruccio BONINO (Italy)
- 08:30 Natural history of HBV and long-term outcome under treatment - Yun-Fan LIAW (Taiwan)
-
08:50
How to prevent, diagnose and overcome resistance under nucleos(t)ide analogs ?
- Fabien ZOULIM (France)
Download
-
09:10
New endpoints. Back to the future with Australia Antigen ?
- Maurizia BRUNETTO (Italy)
Download
- 09:30 Round table - All speakers
- 10:00 - 10:30 Coffee Break
-
10:30 - 11:30
HBeAg-positive chronic hepatitis B
Chairs :
Geoffrey DUSHEIKO (UK) Stanislas POL (France)
-
10:45
Why do I treat my patients with pegylated interferon ?
- George LAU (Hong Kong)
Download
- 11:00 Round table - All Speakers
-
11:30 - 12:30
HBeAg negative chronic hepatitis B
Chairs :
Stephanos HADZIYANNIS (Greece) Jean-Pierre ZARSKI (France)
-
11:30
Why do I treat my patients with nucleos(t)ide analogs ?
- Pietro LAMPERTICO (Italy)
Download
-
11:45
Why do I treat my patients with pegylated interferon ?
- Robert PERRILLO (USA)
Download
- 12:00 Round table - All speakers
-
12:30 - 14:00 Luncheons Room 1
Hepatitis B: predictors and endpoints revisited?
Chair: Feruccio BONINO (Italy)
Speaker:
Rami MOUCARI (United Arab Emirates)
Download
Room 2
How to optimize the management of my HBeAg negative patient?
Chair: Jean-Pierre ZARSKI (France)
Speaker:
Pietro LAMPERTICO (Italy)
Download
Room 3
End stage HBV-related liver disease: what’s left to do?
Chair: Massimo COLOMBO (Italy)
Speaker:
François DURAND (France)
Download
Room 4
How to manage patients with hepatitis B with limited access to care ?
Chair: Robert PERRILLO (USA)
Room 5
French Luncheon : comment prendre en charge les patients atteints d’hépatite B avec les médicaments disponibles dans mon pays
Chair: Christian TREPO (France)
- 14:00 EASL clinical pratice guidelines : management of chronic hepatitis B - Patrick MARCELLIN (France)
-
14:15 - 15:15
Chairs :
Cihan YURDAYDIN (Turkey) Didier SAMUEL (France)
-
14:15
Hepatitis B and pregnancy : an underestimated issue
- Maureen JONAS (USA)
Download
-
14:35
Hepatitis D: the come back ?
- Mario RIZZETTO (Italy)
Download
-
14:55
Clinical case
- Marion PETERS (USA)
Download
-
15:15 - 16:15
Hepatocellular carcinoma
Chairs :
Adrian DI BISCEGLIE (USA) Rafael ESTEBAN (Spain)
-
15:15
Screening and diagnosis of hepatocellular carcinoma
- Massimo COLOMBO (Italy)
Download
-
15:35
New drugs for hepatocellular carcinoma
- Jordi BRUIX (Spain)
Download
- 15:55 Round table
-
16:15
Conclusion and perspectives
-
Patrick MARCELLIN (France)
Download